Teladoc Health (NYSE:TDOC) Price Target Cut to $25.00

Teladoc Health (NYSE:TDOC) had its price target lowered by Canaccord Genuity Group from $28.00 to $25.00 in a report released on Friday, Benzinga reports. The brokerage currently has a buy rating on the health services provider’s stock.

TDOC has been the subject of several other reports. Truist Financial reduced their target price on Teladoc Health from $23.00 to $17.00 and set a hold rating for the company in a research note on Wednesday, March 6th. Needham & Company LLC reiterated a hold rating on shares of Teladoc Health in a report on Friday. Barclays cut their target price on shares of Teladoc Health from $26.00 to $25.00 and set an overweight rating for the company in a research note on Wednesday, February 21st. Piper Sandler decreased their price target on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating on the stock in a research note on Wednesday, February 21st. Finally, Cantor Fitzgerald began coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an overweight rating and a $22.00 price objective for the company. Twelve equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of Hold and an average target price of $18.73.

Teladoc Health Stock Performance

NYSE TDOC opened at $13.40 on Friday. The firm has a market capitalization of $2.27 billion, a P/E ratio of -9.50 and a beta of 0.94. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The firm’s fifty day moving average price is $14.69 and its two-hundred day moving average price is $17.67. Teladoc Health has a 1 year low of $12.65 and a 1 year high of $30.41.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The firm had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. During the same period in the previous year, the company posted ($0.37) earnings per share. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. As a group, research analysts anticipate that Teladoc Health will post -1.06 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In related news, CAO Richard J. Napolitano sold 3,765 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $54,667.80. Following the completion of the sale, the chief accounting officer now owns 18,077 shares of the company’s stock, valued at $262,478.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Jason N. Gorevic sold 53,755 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $780,522.60. Following the completion of the transaction, the chief executive officer now owns 653,073 shares of the company’s stock, valued at approximately $9,482,619.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Richard J. Napolitano sold 3,765 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $54,667.80. Following the sale, the chief accounting officer now owns 18,077 shares of the company’s stock, valued at $262,478.04. The disclosure for this sale can be found here. Insiders sold 135,441 shares of company stock valued at $2,038,251 in the last three months. Corporate insiders own 1.63% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of TDOC. Commonwealth Equity Services LLC increased its position in Teladoc Health by 5.7% during the 3rd quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock worth $1,505,000 after purchasing an additional 4,344 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its holdings in shares of Teladoc Health by 49.4% during the third quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider’s stock worth $8,437,000 after buying an additional 149,976 shares in the last quarter. Raymond James & Associates lifted its stake in shares of Teladoc Health by 0.9% in the 3rd quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock valued at $4,243,000 after acquiring an additional 2,029 shares during the last quarter. Mackenzie Financial Corp boosted its holdings in shares of Teladoc Health by 83.7% during the 3rd quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock valued at $570,000 after acquiring an additional 14,050 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Teladoc Health by 8.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock worth $946,000 after acquiring an additional 4,129 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.